封面
市场调查报告书
商品编码
1935597

全球干血斑采集卡市场规模、份额、趋势及成长分析报告(2026-2034年)

Global Dried Blood Spot Collection Cards Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2025 年,干血斑采集卡市场规模将达到 3.9563 亿美元,到 2034 年将达到 6.3349 亿美元,2026 年至 2034 年的复合年增长率为 5.37%。

受临床和科研领域对便捷高效检体采集方法的需求不断增长的推动,干血斑采集卡市场正经历显着增长。干血斑 (DBS) 采样具有诸多优势,包括操作简单、运输成本低以及可在室温下保存样本。随着就地检验和远距离诊断的日益普及,DBS 技术的应用也蓬勃发展,尤其是在新生儿筛检、传染病检查和治疗药物监测等领域。

此外,干血斑(DBS)技术的进步,包括新型采集卡和分析方法的开发,提高了此采集技术的准确性和可靠性。材料和设计的创新提高了样品稳定性,并促进了分析物的萃取,从而获得了更准确的结果。与质谱和液相层析法等先进分析技术的结合也拓展了DBS的应用范围,进一步推动了市场成长。

此外,诊断领域对研发的日益重视正在推动干血斑采集卡市场的创新。製造商、医疗机构和研究机构之间的合作正在推动干血斑技术的进步,确保新产品能够满足不断变化的市场需求。人们对干血斑采样在提高患者依从性和检测可及性方面的优势认识不断提高,也促进了该市场的扩张。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球干血斑采集卡市场(依应用领域划分)

  • 市场分析、洞察与预测
  • 新生儿筛检(NBS)
  • 传染病检查
  • 治疗药物监测
  • 法医学
  • 合约研究组织/研发
  • 其他的

5. 全球干血斑采集卡市场(依卡片类型划分)

  • 市场分析、洞察与预测
  • Whatman 903
  • 阿赫尔斯特伦 226
  • FTA
  • 其他的

6. 全球干血斑采集卡市场依最终用途划分

  • 市场分析、洞察与预测
  • 医院和诊所
  • 诊断中心
  • 其他的

7. 全球干血斑采集卡市场(依地区划分)

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商格局(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Hemaxis
    • Danaher Corporation
    • Shimadzu
    • PerkinElmer Inc
    • QIAGEN
    • Eastern Business Forms Inc
    • Ahlstrom
    • ARCHIMED Life Science GmbH
    • CENTOGENE NV
    • Spot On Sciences
    • Everlywell Inc
    • Neoteryx
    • Advance DX
简介目录
Product Code: VMR11211805

The Dried Blood Spot Collection Cards Market size is expected to reach USD 633.49 Million in 2034 from USD 395.63 Million (2025) growing at a CAGR of 5.37% during 2026-2034.

The dried blood spot collection cards market is experiencing significant growth, driven by the increasing demand for convenient and efficient sample collection methods in clinical and research settings. Dried blood spot (DBS) sampling offers several advantages, including ease of use, reduced transportation costs, and the ability to store samples at room temperature. As the focus on point-of-care testing and remote diagnostics grows, the adoption of DBS technology is surging, particularly in applications such as newborn screening, infectious disease testing, and therapeutic drug monitoring.

Moreover, advancements in DBS technology, including the development of novel collection cards and analytical methods, are enhancing the accuracy and reliability of this sampling technique. Innovations in materials and design are improving the stability of samples and facilitating the extraction of analytes, leading to more precise results. The integration of DBS with advanced analytical techniques, such as mass spectrometry and liquid chromatography, is also expanding its applications and driving market growth.

Furthermore, the increasing focus on research and development in the field of diagnostics is fostering innovation in the dried blood spot collection cards market. Collaborations between manufacturers, healthcare providers, and research institutions are driving advancements in DBS technology, ensuring that new products meet the evolving needs of the market. The growing awareness of the benefits of DBS sampling in improving patient compliance and access to testing is also contributing to the expansion of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • New Born Screening (NBS)
  • Infectious Diseases Testing
  • Therapeutic Drug Monitoring
  • Forensics
  • CRO/Research
  • Other

By Card Type

  • Whatman 903
  • Ahlstrom 226
  • FTA
  • Others

By End Use

  • Hospitals & Clinics
  • Diagnostics centers
  • Others

COMPANIES PROFILED

  • Hemaxis, Danaher Corporation, Shimadzu, PerkinElmer Inc, QIAGEN, Eastern Business Forms Inc, Ahlstrom, ARCHIMED Life Science GmbH, CENTOGENE NV, Spot On Sciences, Everlywell Inc, Neoteryx, Advance DX

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. New Born Screening (NBS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Infectious Diseases Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Therapeutic Drug Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. CRO/Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY CARD TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Card Type
  • 5.2. Whatman 903 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ahlstrom 226 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. FTA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnostics centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Application
    • 7.2.2 By Card Type
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Application
    • 7.3.2 By Card Type
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Application
    • 7.4.2 By Card Type
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Application
    • 7.5.2 By Card Type
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Application
    • 7.6.2 By Card Type
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRIED BLOOD SPOT COLLECTION CARDS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Hemaxis
    • 9.2.2 Danaher Corporation
    • 9.2.3 Shimadzu
    • 9.2.4 PerkinElmer Inc
    • 9.2.5 QIAGEN
    • 9.2.6 Eastern Business Forms Inc
    • 9.2.7 Ahlstrom
    • 9.2.8 ARCHIMED Life Science GmbH
    • 9.2.9 CENTOGENE N.V
    • 9.2.10 Spot On Sciences
    • 9.2.11 Everlywell Inc
    • 9.2.12 Neoteryx
    • 9.2.13 Advance DX